Differential effect of drug interference in immunogenicity assays
Authors:
- Henk de VriezeHVHenk de Vrieze
- Diana WoutersDWDiana Wouters
- Gerrit-Jan WolbinkGWGerrit-Jan Wolbink
- Joep KillesteinJKJoep Killestein
- Els R. de GrootEGEls R. de Groot
- Lucien A. AardenLALucien A. Aarden
- Theo RispensTRTheo Rispens
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 372 (1-2) , 196-203
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4Journal of Pharmaceutical and Biomedical Analysis, 2011
- A novel method for the detection of antibodies to adalimumab in the presence of drug reveals “hidden” immunogenicity in rheumatoid arthritis patientsJournal of Immunological Methods, 2010
- Strategies and challenges for the next generation of therapeutic antibodiesNature Reviews Immunology, 2010
- Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactionsAllergy, 2010
- HAHA – nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technologyJournal of Pharmaceutical and Biomedical Analysis, 2010
- Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formationAnnals of the Rheumatic Diseases, 2009
- Molecular engineering and design of therapeutic antibodiesCurrent Opinion in Immunology, 2008
- Considerations for the development of therapeutic monoclonal antibodiesCurrent Opinion in Immunology, 2008
- Immunogenicity of anti-tumor necrosis factor antibodies—toward improved methods of anti-antibody measurementCurrent Opinion in Immunology, 2008
- Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2007